Antimicrobial Peptides (AMPs) Against Human Pathogens
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Peptides".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 12
Special Issue Editor
Interests: antimicrobial peptides (AMPs); molecular biology; synthetic and bioengineered peptide; biochemistry and virology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial peptides (AMPs) have emerged as one of the most promising alternatives to conventional antibiotics in the fight against human pathogens. These naturally occurring molecules exhibit broad-spectrum activity against bacteria, viruses, fungi, and parasites, often with unique mechanisms that reduce the likelihood of resistance development. Beyond their direct antimicrobial effects, AMPs can also modulate the immune response, promote wound healing, and influence microbiome balance, making them highly versatile therapeutic candidates.
This Special Issue will bring together cutting-edge research and reviews focused on the discovery, design, and application of AMPs against clinically relevant pathogens. We particularly welcome contributions addressing novel mechanisms of action, structure–function relationships, synthetic and bioengineered peptide strategies, delivery systems, clinical trials, and the role of AMPs in overcoming antimicrobial resistance.
By providing a platform for interdisciplinary discussion, this Special Issue aims to highlight recent advances in AMP research and inspire innovative approaches toward their translation into effective therapies for human health.
We look forward to receiving your contributions.
Dr. Pedro Souza
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial peptides (AMPs)
- mechanisms
- structure–function relationships
- synthetic and bioengineered peptides
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
